FR2604707B1 - Procede de preparation d'un compose therapeutique actif - Google Patents

Procede de preparation d'un compose therapeutique actif

Info

Publication number
FR2604707B1
FR2604707B1 FR8708342A FR8708342A FR2604707B1 FR 2604707 B1 FR2604707 B1 FR 2604707B1 FR 8708342 A FR8708342 A FR 8708342A FR 8708342 A FR8708342 A FR 8708342A FR 2604707 B1 FR2604707 B1 FR 2604707B1
Authority
FR
France
Prior art keywords
preparation
therapeutic compound
active therapeutic
active
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8708342A
Other languages
English (en)
Other versions
FR2604707A1 (fr
Inventor
Jyrki Lamsa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Farmos Yhtyma Oy
Original Assignee
Farmos Yhtyma Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmos Yhtyma Oy filed Critical Farmos Yhtyma Oy
Publication of FR2604707A1 publication Critical patent/FR2604707A1/fr
Application granted granted Critical
Publication of FR2604707B1 publication Critical patent/FR2604707B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/50—Three nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FR8708342A 1986-10-07 1987-06-16 Procede de preparation d'un compose therapeutique actif Expired FR2604707B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI864046A FI864046A (fi) 1986-10-07 1986-10-07 Foerfarande foer framstaellning av en terapeutiskt aktiv foerening.

Publications (2)

Publication Number Publication Date
FR2604707A1 FR2604707A1 (fr) 1988-04-08
FR2604707B1 true FR2604707B1 (fr) 1989-06-09

Family

ID=8523270

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8708342A Expired FR2604707B1 (fr) 1986-10-07 1987-06-16 Procede de preparation d'un compose therapeutique actif

Country Status (18)

Country Link
US (1) US4866174A (fr)
EP (1) EP0270201B1 (fr)
JP (1) JPS6396175A (fr)
KR (1) KR880005095A (fr)
AT (1) ATE61584T1 (fr)
AU (1) AU590431B2 (fr)
CA (1) CA1268766A (fr)
DE (1) DE3768617D1 (fr)
DK (1) DK348687A (fr)
ES (1) ES2021048B3 (fr)
FI (2) FI864046A (fr)
FR (1) FR2604707B1 (fr)
HU (1) HUT44533A (fr)
IL (1) IL83351A0 (fr)
NO (1) NO872810L (fr)
NZ (1) NZ221011A (fr)
PT (1) PT85392B (fr)
ZA (1) ZA875174B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI871773A0 (fi) * 1987-04-22 1987-04-22 Farmos Oy Foerfarande foer framstaellning av en terapeutiskt aktiv foerening.
FR2636840B1 (fr) * 1988-09-23 1990-12-21 Norchim Sarl Sel du 6-piperidino-2,4-diaminopyrimidine-3-oxyde et de l'acide aceturique, leur preparation et leur application dermatocosmetologiques
NZ244301A (en) * 1991-09-20 1994-08-26 Merck & Co Inc Preparation of 2-pyridylmethylsulphinylbenzimidazole and pyridoimidazole derivatives from the corresponding sulphenyl compounds
FR2697251B1 (fr) * 1992-10-22 1994-12-02 Synthelabo N-oxydes de dérivés de 1-(4-chlorophényl)-2-[4-[(4-fluorophényl)méthyl] pipéridin-1-yl]éthanol, leur procédé de préparation et leur application en thérapeutique.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3644364A (en) * 1970-03-31 1972-02-22 Upjohn Co Compounds and process
US3998827A (en) * 1971-04-07 1976-12-21 The Upjohn Company 6-amino-4-(substituted piperidino)-1,2-dihydro-1-hydroxy-2-iminopyrimidines
HU177601B (en) * 1978-10-27 1981-11-28 Egyt Gyogyszervegyeszeti Gyar New process for preparing 6-piperidino-2,4-diamino-pyrimidine-3-oxide
DE3064301D1 (en) * 1979-10-18 1983-08-25 Interox Chemicals Ltd Magnesium salts of peroxycarboxylic acids, processes for their preparation and their use as bleaching agents in washing compositions, and processes
US4483781A (en) * 1983-09-02 1984-11-20 The Procter & Gamble Company Magnesium salts of peroxycarboxylic acids

Also Published As

Publication number Publication date
PT85392A (en) 1987-08-01
NO872810D0 (no) 1987-07-06
AU590431B2 (en) 1989-11-02
NO872810L (no) 1988-04-08
ES2021048B3 (es) 1991-10-16
NZ221011A (en) 1990-05-28
FI873933A0 (fi) 1987-09-11
KR880005095A (ko) 1988-06-28
EP0270201A1 (fr) 1988-06-08
ZA875174B (en) 1988-01-20
IL83351A0 (en) 1987-12-31
PT85392B (en) 1990-01-04
AU7551787A (en) 1988-04-14
DK348687D0 (da) 1987-07-07
FI864046A0 (fi) 1986-10-07
FI873933A (fi) 1988-04-08
JPS6396175A (ja) 1988-04-27
FI864046A (fi) 1988-04-08
DE3768617D1 (de) 1991-04-18
EP0270201B1 (fr) 1991-03-13
FI78910B (fi) 1989-06-30
DK348687A (da) 1988-04-08
FI78910C (fi) 1989-10-10
HUT44533A (en) 1988-03-28
US4866174A (en) 1989-09-12
CA1268766A (fr) 1990-05-08
FR2604707A1 (fr) 1988-04-08
ATE61584T1 (de) 1991-03-15

Similar Documents

Publication Publication Date Title
IT1190466B (it) Procedimento di trattamento per forme farmaceutiche di dosaggio rivestite per ridurne la collosita'
MA21120A1 (fr) Procede de preparation de composes pharmalogiquement actifs.
MA21682A1 (fr) Procede de preparation d'agents therapeutiques derives de la quainclidine.
NO871267D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tiazepinforbindelser.
NO871408D0 (no) Forbedringer ved farmasoeytiske akseptable salter.
NO864879L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tiazolforbindelser.
NO883485L (no) Fremgangsmaate for fremstilling av terapeutisk aktive piperidinyl-isokinolinforbindelser.
IT1182199B (it) Procedimento per la preparazione di composti 1,3-diossolan-4-metanolici otticamente attivi
FI871087A0 (fi) Menetelmä terapeuttisesti aktiivisten 1,2,3,4-tetrahydro-3-karbamoyyli-2-tiokso/okso-5-pyrimidiinikarboksyylihappojohdannaisten valmistamiseksi
NO880667D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive arylpiperazinyl-alkylen-fenyl-heterocykliske forbindelser.
PT85491A (en) Process for the preparation of new (benzofuran-2-yl) imidazoles having pharmaceutical activity and their salts
FR2630735B1 (fr) Procede de preparations d'halogenophenols
IT1229522B (it) Procedimento per la preparazione di acido n fosfonometiliminodiacetico.
FR2565590B1 (fr) Procede de preparation d'aminohydroxycephamcarboxylates
FR2604707B1 (fr) Procede de preparation d'un compose therapeutique actif
FR2620702B1 (fr) Procede de preparation d'irones naturelles
FR2603886B1 (fr) Procede de preparation de carbonates d'alkenyle-1
FR2561645B1 (fr) Procede de preparation d'acides hydroxyalkylaminoacetiques
IT1215344B (it) Procedimento per la preparazione di composti ad attivita' anti-ulcera.
FR2610924B1 (fr) Procede de preparation d'hydroxybiphenyles
IT8621066A0 (it) Procedimento per la preparazione di composti eterociclici azotati.
FR2630741B1 (fr) Procede de preparation d'acryloyloxyethoxymethyl-melamines
NO164599C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktivt 7-d-mandelamido-3-(1-sulfometyl-tetrazol-5-yl)-tiometyl-3-cefem-4-karboksylsyre-mononatriumsalt.
FR2577920B1 (fr) Procede de preparation d'acetals
NO863005D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,4,5,6,7,8-heksahydro-2-alkyl-4-aryl-5-okso-1,7-naftyridin-3-karboksylsyreesterderivater.

Legal Events

Date Code Title Description
ST Notification of lapse